2022 Q4 Form 10-Q Financial Statement
#000173112222001869 Filed on November 07, 2022
Income Statement
Concept | 2022 Q4 | 2022 Q3 | 2021 Q4 |
---|
Balance Sheet
Concept | 2022 Q4 | 2022 Q3 | 2021 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $12.77M | $13.94M | |
YoY Change | |||
Cash & Equivalents | $12.77M | $13.94M | $1.803M |
Short-Term Investments | |||
Other Short-Term Assets | $519.7K | $446.7K | |
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $13.29M | $14.39M | $1.892M |
YoY Change | 602.36% | ||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $765.4K | $631.3K | $235.6K |
YoY Change | 224.92% | ||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $7.520K | ||
YoY Change | |||
Other Assets | $0.00 | $0.00 | |
YoY Change | |||
Total Long-Term Assets | $935.0K | $631.3K | $341.1K |
YoY Change | 174.14% | ||
TOTAL ASSETS | |||
Total Short-Term Assets | $13.29M | $14.39M | $1.892M |
Total Long-Term Assets | $935.0K | $631.3K | $341.1K |
Total Assets | $14.22M | $15.02M | $2.233M |
YoY Change | 536.95% | ||
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $99.03K | $39.48K | $13.33K |
YoY Change | 642.73% | ||
Accrued Expenses | $92.77K | $11.69K | $35.13K |
YoY Change | 164.08% | ||
Deferred Revenue | $5.300K | $4.900K | |
YoY Change | |||
Short-Term Debt | $169.9K | $141.2K | |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $453.2K | $197.2K | $690.4K |
YoY Change | -34.36% | ||
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | |
YoY Change | |||
Other Long-Term Liabilities | $68.53K | ||
YoY Change | |||
Total Long-Term Liabilities | $68.53K | $0.00 | |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $453.2K | $197.2K | $690.4K |
Total Long-Term Liabilities | $68.53K | $0.00 | |
Total Liabilities | $521.7K | $197.2K | $690.4K |
YoY Change | -24.43% | ||
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$4.088M | -$2.667M | -$457.6K |
YoY Change | 793.37% | ||
Common Stock | $10.45K | $10.45K | $7.000K |
YoY Change | 49.29% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $13.70M | $14.82M | $1.542M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $14.22M | $15.02M | $2.233M |
YoY Change | 536.95% |
Cashflow Statement
Concept | 2022 Q4 | 2022 Q3 | 2021 Q4 |
---|
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
13940706 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1803285 | usd |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001901305 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
CY2022Q3 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
usd | |
CY2021Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
usd | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
usd | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
pure | ||
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
shares | |
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
shares | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
|||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-09-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-41469 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
FORZA X1, INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
87-3159685 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
3101 S. US-1 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Ft. Pierce | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
FL | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
34982 | ||
dei |
City Area Code
CityAreaCode
|
(772) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
429-2525 | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock, par value $0.001 per share | ||
dei |
Trading Symbol
TradingSymbol
|
FRZA | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
CY2022Q3 | us-gaap |
Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
|
446685 | usd |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
|
88477 | usd |
CY2022Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-2666789 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-457551 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
14821405 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1542449 | usd |
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
No | ||
CY2022Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
15018644 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
2232827 | usd |
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-19192 | usd |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-19192 | usd |
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
CY2021Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-81357 | usd |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-100549 | usd |
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2021Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-85521 | usd |
CY2022Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
10450000 | shares |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-186070 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1542449 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1891762 | usd |
CY2022Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
10450 | usd |
CY2022Q3 | us-gaap |
Assets Current
AssetsCurrent
|
14387391 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
7000 | usd |
CY2022Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
17477744 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
1993000 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
875874 | usd |
CY2021Q4 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
105500 | usd |
CY2022Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
631253 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
235565 | usd |
CY2022Q3 | us-gaap |
Assets
Assets
|
15018644 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
2232827 | usd |
CY2022Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
39484 | usd |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
13333 | usd |
CY2022Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
11690 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
35128 | usd |
CY2022Q3 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
4900 | usd |
CY2022Q3 | us-gaap |
Due To Affiliate Current
DueToAffiliateCurrent
|
141165 | usd |
CY2021Q4 | us-gaap |
Due To Affiliate Current
DueToAffiliateCurrent
|
641917 | usd |
CY2022Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
197239 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
690378 | usd |
CY2022Q3 | us-gaap |
Liabilities
Liabilities
|
197239 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
690378 | usd |
CY2022Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
25000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
25000000 | shares |
CY2022Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
10450000 | shares |
CY2022Q3 | us-gaap |
Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
|
10450000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
|
7000000 | shares |
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-514292 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1028157 | usd |
CY2022Q2 | us-gaap |
Proceeds From Partnership Contribution
ProceedsFromPartnershipContribution
|
500000 | usd |
CY2022Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-652283 | usd |
CY2022Q3 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
14829489 | usd |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0298 | pure | |
CY2022Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
158705 | usd |
CY2022Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-1042663 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
14821405 | usd |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_841_eus-gaap--UseOfEstimates_z9nlLMrrzBHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i><span id="xdx_861_zdK9Ycdj5c52">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States “U.S. GAAP” requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. Included in those estimates are assumptions about useful life of fixed assets. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> | ||
CY2022Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
13940706 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1803285 | usd |
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zsvrVfqtSBOi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><span id="xdx_864_zlHVcPXMm2Pg">Concentrations of Credit and Business Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The Company minimizes the concentration of credit risk associated with its cash by maintaining its cash with high quality federally insured financial institutions. However, cash balances in excess of the Federal Deposit Insurance Corporation (“FDIC”) insured limit of $<span id="xdx_90A_ecustom--FdicInsuredLimit_iI_c20220930_zZL8VFykEoA6" title="FDIC insured limit">250,000</span> are at risk. As of September 30, 2022 and December 31, 2021, the Company had $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_c20220930_pp0p0" title="FDIC excess amount">13,632,579</span> and $<span id="xdx_90F_eus-gaap--CashFDICInsuredAmount_c20211231_pp0p0" title="FDIC excess amount">1,492,019</span>, respectively, in excess of FDIC insured limits.</p> | ||
CY2022Q3 | FRZA |
Fdic Insured Limit
FdicInsuredLimit
|
250000 | usd |
CY2022Q3 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
13632579 | usd |
CY2021Q4 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
1492019 | usd |
CY2022Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
657616 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
238773 | usd |
CY2022Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
26363 | usd |
CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3208 | usd |
CY2022Q3 | us-gaap |
Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
|
631253 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
|
235565 | usd |
CY2022Q3 | us-gaap |
Due To Affiliate Current
DueToAffiliateCurrent
|
141165 | usd |
CY2021Q4 | us-gaap |
Due To Affiliate Current
DueToAffiliateCurrent
|
641917 | usd |
us-gaap |
Payments For Rent
PaymentsForRent
|
3400 | usd | |
CY2022Q3 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
8986 | usd |
CY2021Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
16090 | usd |
CY2022Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
2704 | usd |
CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
19038 | usd |
CY2022Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
11690 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
35128 | usd |
CY2022Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
13940706 | usd |
CY2022Q3 | FRZA |
Working Capital
WorkingCapital
|
14190152 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1803285 | usd |
CY2021Q4 | FRZA |
Working Capital
WorkingCapital
|
1201384 | usd |
us-gaap |
Short Term Lease Payments
ShortTermLeasePayments
|
2200 | usd | |
us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
2200 | usd | |
CY2022Q3 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
172500 | shares |
CY2022Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
6.25 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Expiration Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
|
2027-08-16 | ||
FRZA |
Warrant Activity
WarrantActivity
|
0 | usd | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.15 | pure | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.00 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
816500 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
5.00 | ||
FRZA |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2
|
P10Y | ||
CY2022Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
816500 | shares |
CY2022Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
5.00 | |
us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
|
P9Y10M13D | ||
CY2022Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
47194 | shares |
CY2022Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
5.00 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P9Y10M13D | ||
CY2022Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
769306 | shares |